PP
ALBO

PDT Partners’s Albireo Pharma Inc ALBO Stock Holding History

PDT Partners’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,587
Closed -$510K – 758
2022
Q4 		$510K Buy
+23,587
New +$498K 0.08% 382

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PDT Partners's ALBO Position: Q1 2023 in Review

PDT Partners sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 23,587 shares — an estimated $510K sold.

PDT Partners first reported a position in ALBO in Q4 2022 and held it in 1 quarter. The position peaked at $510K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • PDT Partners reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • PDT Partners sold 23,587 Albireo Pharma Inc shares in Q1 2023, an estimated $510K.
  • PDT Partners first reported a position in Albireo Pharma Inc in Q4 2022 and held it in 1 quarter.
  • PDT Partners's Albireo Pharma Inc position peaked at $510K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.